Clinical Trial

Medeliver Intracranial Drug Coated Balloon Catheter for Symptomatic Intracranial Atherosclerotic Stenosis

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the safety and efficacy of the Medeliver® Intracranial Drug-Coated Balloon Catheter (developed by Beijing Jiu Shi Shen Kang Medical Technology Co., Ltd.) in the endovascular treatment of symptomatic intracranial atherosclerotic stenosis.
Trial Details
NCT Number NCT07542938
Lead Sponsor Xuanwu Hospital, Beijing
Conditions Symptomatic Intracranial Atherosclerotic Stenosis
Enrollment 264 participants
Start Date 2026-04-15
Primary Completion 2026-11-30 (estimated)
Study Completion 2027-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-21